Johanna Friedl Naderer Dyne Therapeutics, Inc. (DYN) insider trading activity

Johanna Friedl Naderer is Chief Commercial Officer of Dyne Therapeutics, Inc.. Currently has a direct ownership of 96,200 shares of DYN, which is worth approximately $2.35 Million. The most recent transaction as insider was on Dec 04, 2024, when has been sold 37,800 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 96.2K

64.73% 3M change

n/a 12M change

Total Value Held $2.35 Million

Johanna Friedl-Naderer Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Dec 04 2024	BUY Grant, award, or other acquisition	-	37,800 Added 28.21%	96,200 Common Stock
Sep 03 2024	BUY Grant, award, or other acquisition	-	58,400 Added 50.0%	58,400 Common Stock

Also insider at

VIR

Vir Biotechnology, Inc. Healthcare

EVP & Chief Operating Officer